NCT02466919View on ClinicalTrials.gov

Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Pantoprazole

H. pylori eradication therapy

DRUG

Amoxicillin

H. pylori eradication therapy

DRUG

Metronidazole

H. pylori eradication therapy

DRUG

Levofloxacin

H. pylori eradication therapy

DRUG

Clarithromycin

H. pylori eradication therapy

All Listed Sponsors
collaborator

Ministry of Health and Welfare, Taiwan

OTHER_GOV

lead

Chung-Tai Wu

OTHER

NCT02466919 - Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients | Biotech Hunter | Biotech Hunter